Stephens Consulting, LLC Collegium Pharmaceutical, Inc Call Options Transaction History
Stephens Consulting, LLC
- $399 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding COLL
# of Institutions
251Shares Held
37.2MCall Options Held
59.3KPut Options Held
9.5K-
Black Rock Inc. New York, NY5.79MShares$156 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$71 Million1.45% of portfolio
-
Rubric Capital Management LP New York, NY2.35MShares$63.2 Million1.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$61.4 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$57.6 Million0.15% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $918M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...